Please use this identifier to cite or link to this item: http://hdl.handle.net/10419/96577
Authors: 
Wagner, Stefan
Wakeman, Simon
Year of Publication: 
2014
Series/Report no.: 
ESMT Working Paper 14-01
Abstract: 
Patent-based measures are frequently used as indicators in empirical research on innovation and technology as well as on firms' strategies and organizational choices to characterize inventions or, more generally, innovative activities and the technological capabilities of organizations. A clear correlation between the value of an invention and a number of patent indicators such as the number of citations received has been established. However, there is much less evidence of what patent-based indicators tell us about outcomes beyond patent value. Using data from the pharmaceutical industry, we investigate the relationship between the most frequently used indicators and the outcomes from the product development process. Our findings draw a complex picture regarding the information content of various patent indicators that bear important implications for the use and the proper interpretation of these indicators in settings where they are employed to describe outcomes beyond the patent system itself.
Subjects: 
patent indicators
patent system
product commercialization
pharmaceutical industry
drug development
Persistent Identifier of the first edition: 
Document Type: 
Working Paper

Files in This Item:
File
Size
424.71 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.